In one clinical trial in patients with a history of pulmonary complications bronchospasm was reported as a possibly related adverse event in two patients and a causal relationship could not be fully excluded.
Uuringu käigus tekkis kahel patsiendil kõrvaltoimena bronhospasm, mille põhjuslikku seost ravimi kasutamisega ei saanud täielikult välistada.